VanEck Pharmaceutical ETF
PPH
#1334
ETF rank
NZ$1.66 B
Marketcap
๐Ÿ‡บ๐Ÿ‡ธ US
Market
NZ$191.39
Share price
1.38%
Change (1 day)
37.21%
Change (1 year)

Expense ratio and fees for VanEck Pharmaceutical ETF (PPH)

Expense Ratio

Expense Ratio as of May 2025: 0.36%

Gross Expense Ratio

Gross Expense Ratio as of August 2026: 0.36%

Net Expense Ratio

Net Expense Ratio as of August 2026: 0.36%